Will Rosellini, JD, MBA
Will Rosellini is Founder and Chairman of Microtransponder Inc. and Rosellini Scientific, LLC. As the previous CEO of Microtransponder, Will led a team that raised $12M in private equity investment and $11M in NIH funding to support the development of a number of different medical devices through preclinical and clinical studies. During his tenure, he was named MTBC Tech Titan, GSEA Entrepreneur of the Year and is currently a finalist for the O’Dell award given by the Texas Academy of Science, Engineering and Medicine.
Will is an inventor on three patent applications, a published author in peer-reviewed journals in the area of bioinformatics and databases and has testified to Congress on the importance of non-dilutive funding for inventors and researchers. He is also a scientific advisor to IPNav, a global advisory firm that has represented inventors in over $600M in licensing revenues. Currently, Will is serving as a consultant on the video game, Deus Ex: Human Revolution, from Square Enix and Eidos Montreal. He wrote many of the scientific-based mechanical augmentation background notes and provided guidance for the developers on the bleeding-edge neurotechnology that is currently in human trials or late-stage development.
Prior to founding Microtransponder, Will founded and sold Texas Onsite Dental, which serviced nursing homes and assisted living centers with mobile dental practices.
Will holds a BA in Economics from the University of Dallas, an MS of Accounting and an MBA from the University of Texas, an MS of Neuroscience from University of Texas, a Juris Doctorate from Hofstra Law, an MS of Computational Biology from Rutgers, and an MS of Regulatory Science from USC. He is currently pursuing a PhD in Neuroscience. His PhD work is focused on evaluating the safety and efficacy of a novel form of neurostimulation, called voltage-controlled capacitive discharge (VCCD), invented by Dr. Larry Cauller. In addition, Will was a professional baseball pitcher for the Arizona Diamondbacks.